Research > ETFs > ETF / ETP Commentary > 

Beyond AI Stocks: As Markets Broaden, Look to Active ETFs

AI headlines are getting spooky, but what about AI stocks? The hyperscalers and megacap tech firms make outsized contributions to market movement. As markets broaden, however, other opportunities can be found, that offer upside without adding AI stocks-driven concentration risk. Active ETFs like the T. Rowe Price Blue Chip Growth (TCHP B-) and the T. Rowe Price Small-Mid Cap ETF (TMSL B+) for example, considers factors like earnings, profitability, and relative valuation to find upside.Key Takeaways: Recent analysis from T. Rowe Price speaks to the case for a broadening opportunity set outside of AI stocks. While AI stocks and hyperscalers have contributed massively to market growth, the cash flow picture has darkened. TMSL’s active approach, leaning on fundamental research to target small- and midcaps, can find earnings performers. TCHP’s active approach can find strong growth performers among blue chip firms. T. Rowe Price portfolio manager Paul Greene recently analyzed the shifting landscape for AI stocks and their place in the broadening equities market. The piece, titled “Why investors should prioritize durable growth when the market does not,” honed in on the difference between earnings growth and earnings durability. “The market may not fully appreciate the potential durability of the hyperscalers’ business models while their free cash flow is under pressure and hardware companies benefiting from bottlenecks offer the prospect of impressive near‑term earnings growth,” he wrote. “In our view, this dislocation creates a favorable risk/reward setup for patient growth investors.” Indeed, while AI stocks have notable tailwinds, they have obfuscated what he called an “excluded middle.” That includes companies offering steady, above-average earnings growth over longer term periods. Active investing, relying on fundamental research and analysis, can help identify firms to leverage that conviction. Both TCHP, managed by Paul Green, and equities outside of large/megacap stocks through small- and midcap exposure with the T. Rowe Price Small/Mid Cap ETF (TMSL), managed by Jodi Love, can appeal. TCHP uses that research to find firms with seasoned management and dividend growth among the top names. TMSL leans on T. Rowe Price’s own research capabilities and seasoned managers to do so, assessing stocks for value and growth metrics. The fund’s bottom-up approach considers earnings quality, profitability, projected growth rates, and more. That has helped TMSL return 18.3% over the last 12 months according to T. Rowe Price data. The fund invests in financials as one of its largest sectors, an area that can offer that steady earnings growth long term. TCHP has returned 3.9% in that time. While AI stocks have great appeal, diversifying into steady earnings performers has a place in portfolios, too. For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.